GLP3-R
30mg
⚠️ Not for human consumption. Research purposes only.
Description
GLP3-R is a triple-receptor agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. It has been studied in preclinical and clinical trial models for its multi-receptor pharmacology, investigating the synergistic effects of concurrent incretin and glucagon receptor activation on metabolic signaling pathways.
Key Areas of Study
- Triple-receptor agonist pharmacology research
- incretin signaling studies
- glucagon receptor activation analysis
- multi-pathway metabolic modeling
Mechanisms Being Evaluated
GLP3-R engages three distinct G-protein-coupled receptors: GLP-1R (promoting incretin signaling), GIPR (modulating glucose-dependent insulinotropic polypeptide pathways), and GCGR (activating glucagon-mediated hepatic signaling). Research has characterized its effects on cAMP-mediated signal transduction across these receptor systems.
Commonly Researched Uses
Multi-receptor agonist pharmacology research, incretin pathway studies, glucagon receptor signaling investigations, metabolic hormone receptor cross-talk analysis